vs
HA Sustainable Infrastructure Capital, Inc.（HASI）与Orthofix Medical Inc.（OFIX）财务数据对比。点击上方公司名可切换其他公司
Orthofix Medical Inc.的季度营收约是HA Sustainable Infrastructure Capital, Inc.的1.9倍（$219.9M vs $114.8M），Orthofix Medical Inc.净利率更高（-1.0% vs -46.8%，领先45.8%），HA Sustainable Infrastructure Capital, Inc.同比增速更快（13.3% vs 2.0%），过去两年Orthofix Medical Inc.的营收复合增速更高（8.0% vs 4.2%）
HA可持续基础设施资本公司（HASI）是一家聚焦可持续基础设施领域的专业投资机构，业务覆盖可再生能源、能效提升、可持续地产及低碳公用事业板块，主要在北美市场运营，为合格绿色项目提供长期资本支持，为投资者创造稳定的经风险调整后回报。
Orthofix医疗是全球知名骨科医疗器械企业，专注于研发、生产及销售脊柱植入物、骨科创伤产品、骨生长刺激治疗设备及再生医疗产品，服务全球多地的骨科医师与医疗机构，致力于提升肌肉骨骼疾病患者的诊疗效果。
HASI vs OFIX — 直观对比
营收规模更大
OFIX
是对方的1.9倍
$114.8M
营收增速更快
HASI
高出11.4%
2.0%
净利率更高
OFIX
高出45.8%
-46.8%
两年增速更快
OFIX
近两年复合增速
4.2%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $114.8M | $219.9M |
| 净利润 | $-53.8M | $-2.2M |
| 毛利率 | — | 71.1% |
| 营业利润率 | -57.4% | 0.2% |
| 净利率 | -46.8% | -1.0% |
| 营收同比 | 13.3% | 2.0% |
| 净利润同比 | -176.7% | 92.4% |
| 每股收益（稀释后） | $-0.38 | $-0.05 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收HASIOFIX
| Q4 25 | $114.8M | $219.9M | ||
| Q3 25 | $103.1M | $205.6M | ||
| Q2 25 | $85.7M | $203.1M | ||
| Q1 25 | $96.9M | $193.6M | ||
| Q4 24 | $101.3M | $215.7M | ||
| Q3 24 | $82.0M | $196.6M | ||
| Q2 24 | $94.5M | $198.6M | ||
| Q1 24 | $105.8M | $188.6M |
净利润HASIOFIX
| Q4 25 | $-53.8M | $-2.2M | ||
| Q3 25 | $83.3M | $-22.8M | ||
| Q2 25 | $98.4M | $-14.1M | ||
| Q1 25 | $56.6M | $-53.1M | ||
| Q4 24 | $70.1M | $-29.1M | ||
| Q3 24 | $-19.6M | $-27.4M | ||
| Q2 24 | $26.5M | $-33.4M | ||
| Q1 24 | $123.0M | $-36.0M |
毛利率HASIOFIX
| Q4 25 | — | 71.1% | ||
| Q3 25 | — | 72.2% | ||
| Q2 25 | — | 68.7% | ||
| Q1 25 | — | 62.8% | ||
| Q4 24 | — | 69.0% | ||
| Q3 24 | — | 68.7% | ||
| Q2 24 | — | 67.8% | ||
| Q1 24 | — | 67.5% |
营业利润率HASIOFIX
| Q4 25 | -57.4% | 0.2% | ||
| Q3 25 | — | -8.3% | ||
| Q2 25 | — | -7.9% | ||
| Q1 25 | 84.7% | -25.2% | ||
| Q4 24 | 90.9% | -5.3% | ||
| Q3 24 | -32.1% | -9.6% | ||
| Q2 24 | 39.5% | -12.5% | ||
| Q1 24 | — | -15.6% |
净利率HASIOFIX
| Q4 25 | -46.8% | -1.0% | ||
| Q3 25 | 80.8% | -11.1% | ||
| Q2 25 | 114.9% | -6.9% | ||
| Q1 25 | 58.4% | -27.4% | ||
| Q4 24 | 69.2% | -13.5% | ||
| Q3 24 | -23.9% | -13.9% | ||
| Q2 24 | 28.1% | -16.8% | ||
| Q1 24 | 116.3% | -19.1% |
每股收益（稀释后）HASIOFIX
| Q4 25 | $-0.38 | $-0.05 | ||
| Q3 25 | $0.61 | $-0.57 | ||
| Q2 25 | $0.74 | $-0.36 | ||
| Q1 25 | $0.44 | $-1.35 | ||
| Q4 24 | $0.58 | $-0.76 | ||
| Q3 24 | $-0.17 | $-0.71 | ||
| Q2 24 | $0.23 | $-0.88 | ||
| Q1 24 | $0.98 | $-0.95 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $110.2M | $82.0M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $2.7B | $450.0M |
| 总资产 | $8.2B | $850.6M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资HASIOFIX
| Q4 25 | $110.2M | $82.0M | ||
| Q3 25 | $301.8M | $62.9M | ||
| Q2 25 | $86.5M | $65.6M | ||
| Q1 25 | $67.4M | $58.0M | ||
| Q4 24 | $129.8M | $83.2M | ||
| Q3 24 | $44.1M | $30.1M | ||
| Q2 24 | $145.7M | $26.4M | ||
| Q1 24 | $61.4M | $27.0M |
总债务HASIOFIX
| Q4 25 | — | — | ||
| Q3 25 | — | $157.2M | ||
| Q2 25 | — | $157.0M | ||
| Q1 25 | — | $156.9M | ||
| Q4 24 | — | $157.0M | ||
| Q3 24 | — | $118.5M | ||
| Q2 24 | — | $118.0M | ||
| Q1 24 | — | $118.2M |
股东权益HASIOFIX
| Q4 25 | $2.7B | $450.0M | ||
| Q3 25 | $2.7B | $442.5M | ||
| Q2 25 | $2.6B | $458.3M | ||
| Q1 25 | $2.5B | $458.3M | ||
| Q4 24 | $2.4B | $503.1M | ||
| Q3 24 | $2.3B | $525.9M | ||
| Q2 24 | $2.3B | $546.0M | ||
| Q1 24 | $2.3B | $570.3M |
总资产HASIOFIX
| Q4 25 | $8.2B | $850.6M | ||
| Q3 25 | $8.2B | $832.6M | ||
| Q2 25 | $7.6B | $837.2M | ||
| Q1 25 | $7.5B | $823.1M | ||
| Q4 24 | $7.1B | $893.3M | ||
| Q3 24 | $6.7B | $867.9M | ||
| Q2 24 | $6.7B | $882.0M | ||
| Q1 24 | $6.7B | $906.0M |
负债/权益比HASIOFIX
| Q4 25 | — | — | ||
| Q3 25 | — | 0.36× | ||
| Q2 25 | — | 0.34× | ||
| Q1 25 | — | 0.34× | ||
| Q4 24 | — | 0.31× | ||
| Q3 24 | — | 0.23× | ||
| Q2 24 | — | 0.22× | ||
| Q1 24 | — | 0.21× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $167.3M | $27.7M |
| 自由现金流经营现金流 - 资本支出 | — | $16.8M |
| 自由现金流率自由现金流/营收 | — | 7.6% |
| 资本支出强度资本支出/营收 | — | 4.9% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | — | $-1.3M |
8季度趋势，按日历期对齐
经营现金流HASIOFIX
| Q4 25 | $167.3M | $27.7M | ||
| Q3 25 | $-121.8M | $12.4M | ||
| Q2 25 | $79.6M | $11.6M | ||
| Q1 25 | $-37.1M | $-18.4M | ||
| Q4 24 | $5.9M | $23.7M | ||
| Q3 24 | $21.9M | $11.7M | ||
| Q2 24 | $-24.8M | $9.0M | ||
| Q1 24 | $20.9M | $-18.6M |
自由现金流HASIOFIX
| Q4 25 | — | $16.8M | ||
| Q3 25 | — | $2.5M | ||
| Q2 25 | — | $4.5M | ||
| Q1 25 | — | $-25.1M | ||
| Q4 24 | — | $15.2M | ||
| Q3 24 | — | $6.3M | ||
| Q2 24 | — | $-360.0K | ||
| Q1 24 | — | $-29.1M |
自由现金流率HASIOFIX
| Q4 25 | — | 7.6% | ||
| Q3 25 | — | 1.2% | ||
| Q2 25 | — | 2.2% | ||
| Q1 25 | — | -13.0% | ||
| Q4 24 | — | 7.0% | ||
| Q3 24 | — | 3.2% | ||
| Q2 24 | — | -0.2% | ||
| Q1 24 | — | -15.4% |
资本支出强度HASIOFIX
| Q4 25 | — | 4.9% | ||
| Q3 25 | — | 4.8% | ||
| Q2 25 | — | 3.5% | ||
| Q1 25 | — | 3.5% | ||
| Q4 24 | — | 4.0% | ||
| Q3 24 | — | 2.7% | ||
| Q2 24 | — | 4.7% | ||
| Q1 24 | — | 5.6% |
现金转化率HASIOFIX
| Q4 25 | — | — | ||
| Q3 25 | -1.46× | — | ||
| Q2 25 | 0.81× | — | ||
| Q1 25 | -0.66× | — | ||
| Q4 24 | 0.08× | — | ||
| Q3 24 | — | — | ||
| Q2 24 | -0.94× | — | ||
| Q1 24 | 0.17× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
HASI
暂无分部数据
OFIX
| Spinal Implants Biologics And Enabling Technologies | $113.6M | 52% |
| Bone Growth Therapies | $68.3M | 31% |
| Other | $22.7M | 10% |
| IT | $5.9M | 3% |
| GB | $3.5M | 2% |
| FR | $3.5M | 2% |
| DE | $2.3M | 1% |
